| Drugs in clinical trials for Alzheimer's disease: the major trends SO Bachurin, EV Bovina, AA Ustyugov Medicinal research reviews 37 (5), 1186-1225, 2017 | 199 | 2017 |
| Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice TA Shelkovnikova, OM Peters, AV Deykin, N Connor-Robson, ... Journal of Biological Chemistry 288 (35), 25266-25274, 2013 | 89 | 2013 |
| Chronic administration of dimebon ameliorates pathology in Tau P301S transgenic mice OM Peters, N Connor-Robson, VB Sokolov, AY Aksinenko, MS Kukharsky, ... Journal of Alzheimer's Disease 33 (4), 1041-1049, 2013 | 69 | 2013 |
| Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice SO Bachurin, TA Shelkovnikova, AA Ustyugov, O Peters, I Khritankova, ... Neurotoxicity research 22 (1), 33-42, 2012 | 53 | 2012 |
| Novel sites of neuroprotective action of Dimebon (latrepirdine) A Ustyugov, E Shevtsova, S Bachurin Molecular neurobiology 52 (2), 970-978, 2015 | 32 | 2015 |
| Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds SO Bachurin, AA Ustyugov, O Peters, TA Shelkovnikova, VL Buchman, ... Doklady. Biochemistry and biophysics 428 (1), 235, 2009 | 30 | 2009 |
| 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment GF Makhaeva, SV Lushchekina, NP Boltneva, OG Serebryakova, ... Bioorganic & medicinal chemistry 25 (21), 5981-5994, 2017 | 27 | 2017 |
| Hsp27 is persistently expressed in zebrafish skeletal and cardiac muscle tissues but dispensable for their morphogenesis NR Tucker, A Ustyugov, AL Bryantsev, ME Konkel, EA Shelden Cell Stress and Chaperones 14 (5), 521-533, 2009 | 26 | 2009 |
| Блокада нейродегенеративных процессов, вызванных протеинопатией, как новый механизм действия нейропротекторных и когнитивно-стимулирующих препаратов СО Бачурин, АА Устюгов, О Петерс, ТА Шелковникова, ВЛ Бухман, ... Доклады Академии Наук 428 (2), 262-265, 2009 | 23 | 2009 |
| A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression N Ninkina, N Connor-Robson, AA Ustyugov, TV Tarasova, ... Scientific reports 5 (1), 1-6, 2015 | 16 | 2015 |
| C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population NY Abramycheva, EV Lysogorskaia, MS Stepanova, MN Zakharova, ... Neurobiology of aging 36 (10), 2908. e5-2908. e9, 2015 | 16 | 2015 |
| Early lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif HK Robinson, AV Deykin, EV Bronovitsky, RK Ovchinnikov, AA Ustyugov, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (5-6), 402-409, 2015 | 16 | 2015 |
| TA Shelkovni kova, VL Bukhman, NN Ninkina SO Bachurin, AA Ustyugov, O Peters Dokl. Akad. Nauk 428, 262, 2009 | 16 | 2009 |
| Dimebon reduces the levels of aggregated amyloidogenic protein forms in detergent-insoluble fractions in vivo AA Ustyugov, TA Shelkovnikova, VS Kokhan, IV Khritankova, O Peters, ... Bulletin of experimental biology and medicine 152 (6), 731, 2012 | 15 | 2012 |
| Новые аспекты патогенеза бокового амиотрофического склероза ВИ Скворцова, СО Бачурин, ОД Разинская, АП Смирнов, ... Журнал неврологии и психиатрии им. СС Корсакова 111 (2), 4-9, 2011 | 14 | 2011 |
| Dimebon does not ameliorate pathological changes caused by expression of truncated (1–120) human alpha-synuclein in dopaminergic neurons of transgenic mice TA Shelkovnikova, AA Ustyugov, S Millership, O Peters, O Anichtchik, ... Neurodegenerative Diseases 8 (6), 430-437, 2011 | 12 | 2011 |
| Chikungunya virus inhibition by synthetic coumarin–guanosine conjugates JR Hwu, WC Huang, SY Lin, KT Tan, YC Hu, FK Shieh, SO Bachurin, ... European journal of medicinal chemistry 166, 136-143, 2019 | 11 | 2019 |
| Alzheimer's Disease–Future Therapy Based on Dendrimers G Aliev, GM Ashraf, VV Tarasov, VN Chubarev, J Leszek, K Gasiorowski, ... Current neuropharmacology 17 (3), 288-294, 2019 | 11 | 2019 |
| Applications of multi-target computer-aided methodologies in molecular design of CNS drugs OA Raevsky, A Mukhametov, VY Grigorev, A Ustyugov, SC Tsay, ... Current medicinal chemistry 25 (39), 5293-5314, 2018 | 11 | 2018 |
| The Y-box binding protein 1 suppresses Alzheimer’s disease progression in two animal models NV Bobkova, DN Lyabin, NI Medvinskaya, AN Samokhin, PV Nekrasov, ... PloS one 10 (9), e0138867, 2015 | 11 | 2015 |
Owen PetersCardiff University, School of BiosciencesVerified email at cardiff.ac.uk
